Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.490
+0.010 (0.40%)
At close: Mar 6, 2026, 4:00 PM EST
2.537
+0.047 (1.89%)
After-hours: Mar 6, 2026, 7:17 PM EST
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $65.99 million as of March 6, 2026. Its market cap has increased by 51.87% in one year.
Market Cap
65.99M
Enterprise Value
50.71M
1-Year Change
51.87%
Ranking
Category
Stock Price
$2.49
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from $62.51M to $65.99M, an increase of 5.57%. That is a compound annual growth rate of 0.89%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XBiotech | 71.19M |
| Impact BioMedical | 70.35M |
| Cingulate | 66.99M |
| MediciNova | 66.94M |
| Actuate Therapeutics | 66.48M |
| InflaRx | 65.71M |
| Q32 Bio | 65.66M |
| TScan Therapeutics | 63.56M |